| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6b71cdc7e3a0d9d0790d662ff77e66a4 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-89
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-44 |
| filingDate |
2010-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_66fd520c8e672f78681fc25f45365397
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_230325c92cc7b30b020f0c5dbaa2e9d8 |
| publicationDate |
2012-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-201204409-A |
| titleOfInvention |
Semisolid pharmaceutical formulations |
| abstract |
The present invention relates to semisolid transdermal pharmaceutical formulation having enhanced stability and bioavailability, wherein the particles are coated by a volatile silicon oil component and the thus obtained suspension is dispersed in a gel, ointment or cream base. |
| priorityDate |
2010-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |